APA

Aoki-Sei S., O'Brien M. C., Ford H., Fujii H., Gilbert D. A., Cooney D. A., Johns D. G., Broder S. & Mitsuya H. (19911202). In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells. : The Journal of infectious diseases.

Chicago

Aoki-Sei S, O'Brien M C, Ford H, Fujii H, Gilbert D A, Cooney D A, Johns D G, Broder S and Mitsuya H. 19911202. In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells. : The Journal of infectious diseases.

Harvard

Aoki-Sei S., O'Brien M. C., Ford H., Fujii H., Gilbert D. A., Cooney D. A., Johns D. G., Broder S. and Mitsuya H. (19911202). In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells. : The Journal of infectious diseases.

MLA

Aoki-Sei S, O'Brien M C, Ford H, Fujii H, Gilbert D A, Cooney D A, Johns D G, Broder S and Mitsuya H. In vitro inhibition of hepatitis B virus replication by 2',3'-dideoxyguanosine, 2',3'-dideoxyinosine, and 3'-azido-2',3'-dideoxythymidine in 2.2.15 (PR) cells. : The Journal of infectious diseases. 19911202.